Business Wire

Announcement from SII Semiconductor Corporation: Change of Company Name

Del

SII Semiconductor Corporation (President: Nobumasa Ishiai, Head Office: Chiba-shi, Chiba; hereinafter “SII Semiconductor”), a subsidiary of Seiko Instruments Inc. (President: Hitoshi Murakami, Head Office: Chiba-shi, Chiba; hereinafter “SII”), that manufactures and sells semiconductors today announced that the company will change its company name to ABLIC Inc. in January 5, 2018.

SII Semiconductor was established in September 2015. Through a joint investment by Development Bank of Japan Inc. (President & CEO: Masanori Yanagi, Head Office: Chiyoda-ku, Tokyo; hereinafter “DBJ”) in January 2016, SII Semiconductor has deployed and expanded its business by succeeding the SII’s semiconductor business. Currently the equity of SII Semiconductor is split to 60% for SII and 40% for DBJ, but SII will transfer its 30% of the equity to DBJ and DBJ will acquire 70% after January 2018. Taking advantage of this opportunity, SII Semiconductor has determined to change its company name for further growth and expansion of its business as a manufacturer specialized in analog semiconductors.

SII Semiconductor continues to strive for enhancing its development function as well as manufacturing capability for semiconductor products featuring low-current consumption, low-voltage operation, and ultra-small package technologies that have been honed in the SII’s well-established history, while promoting M&As, alliances, etc. to be an industry-leading analog semiconductor company on a global basis.

1. New Company Name and Logo

[Name]

ABLIC Inc.

[Logo]

The new company name is ABLIC, a word coined by combining ABLE and an IC (Integrated Circuit), meaning that semiconductor technologies make the impossible possible. The logo is a combination of an arrow pointing upward that expresses growth and a black diamond symbol that expresses an IC. It symbolizes the first initial of the company name, A, and a corporate attitude seeking to develop society as a whole with semiconductors.

2. Date of Changing Company Name

January 5, 2018 (scheduled)

3. Outline of Company

Name     SII Semiconductor Corporation
Capital 9,250 million yen
Date of establishment September 28, 2015
Number of employees 832 (as of March 31, 2017)

Website

http://www.sii-ic.com/en/

Contact information

Seiko Instruments Inc.
Nobuo Abe, +81-43-211-1111 (Japanese inquiry only)
Corporate Communications
pr@sii.co.jp
Online Inquiry: https://krs.bz/sii/m/sii_inquiry_en

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

TechnipFMC, Saipem & Bureau Veritas Sign Partnership with Expert Teleportation21.11.2017 15:27Pressemelding

BUREAU VERITAS, SAIPEM and TECHNIPFMC are teaming up to bring expert tele assistance to on-site operators within the specific context of the Oil & Gas sector (offshore, remote location, ATEX, IECEx, etc.) and have formed a collaborative partnership with EXPERT TELEPORTATION who will lead the project development. The 15-month long project will deliver a hands’ free device (modified smart glasses) adapted to use with personnel protective equipment. The adapted tool will connect an operator located on site anywhere in the world with a remote expert / analyst in real time via audio and video stream. This EXPERT TELEPORTATION project will enable higher operational efficiency, smarter and faster response time, improved safety and a reduced carbon footprint. ABOUT: In an increasingly competit

Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) from EMA in Newly Diagnosed Multiple Myeloma21.11.2017 14:40Pressemelding

Janssen-Cilag International NV today announced the submission of a Type II variation application to the European Medicines Agency (EMA), for the immunotherapy DARZALEX®▼ (daratumumab). The application seeks to broaden the existing marketing authorisation to include daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. “This submission to health authorities takes us one step closer to our goal of redefining combination therapy in multiple myeloma, with the potential to make daratumumab available to more patients throughout the treatment continuum: from newly diagnosed, to heavily pre-treated,” said Dr Catherine Taylor, Haematology Therapeutic Area Lead, Janssen Europe, Middle East and Africa (EMEA). “We look forward to working closely with the

Andersen Global Announces Expansion in Uganda21.11.2017 14:30Pressemelding

Andersen Global is proud to announce a presence in Uganda by way of a Collaboration Agreement with Ligomarc Advocates, a financial and corporate tax and legal firm. The firm is led by Managing Partner, Kabiito Karamagi. The addition of Ligomarc Advocates as a Collaborating Firm of Andersen Global continues the organization’s expansion in Africa. Ligomarc is Andersen Global’s fourth location in Africa. “Integrity, excellence, and putting the client at the center have always been of paramount importance to us, and our collaboration with Andersen Global will allow us to ensure our clients receive the best-in-class service internationally,” commented Kabiito Karamagi. “The team at Andersen shares our values of outstanding, seamless client service and independence—this is a natural fit.” Ligomarc Advocates was founded as a sole practice over fifteen years ago by Ruth Sebatindira,

Keio Plaza Hotel Tokyo Hosts "Sky Jazz Night" Events in the "Premier Grand" Club Lounge21.11.2017 14:00Pressemelding

Keio Plaza Hotel Tokyo (KPH), one of Japan’s most prestigious international hotels located in Shinjuku, Tokyo, will host special jazz events for guests staying in our “Premier Grand” Club Floor on December 7, 8, 14, 15, and 16, 2017. A duo consisting of piano and contrabass artists will perform 30 minutes jazz sessions in our Club Lounge located on the 45th floor at 5:30p.m., 6:30p.m., and 7:30p.m. Guests listening to these jazz sessions can enjoy complimentary hors d’ oeuvres, and alcoholic and non-alcoholic beverages. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171121005017/en/ Club Floor "Premier Grand," Club Lounge (Photo: Business Wire) Our “Premier Grand” Club Floors were renovated and newly opened in December 2016, with guest rooms being fitted with various premium items

SIA Launches a New Digital Platform for Instant Payments21.11.2017 14:00Pressemelding

SIA launches “SIA EasyWay”, the new digital platform which allows banks and other payment service providers (PSPs) to manage at European level the instant payments available from 21 November on EBA Clearing’s RT1 infrastructure developed by SIA, in addition to all other SEPA payment and collection instruments. In fact, as of this date, citizens and companies in 34 countries in the Single Euro Payments Area (SEPA) are able to transfer and receive sums of up to €15,000 per individual transaction in less than 10 seconds through a service available 24 hours a day, 365 days a year, in line with the SEPA Instant Credit Transfer (transfer with real-time and irrevocable credit) scheme of the European Payments Council (EPC). “SIA EasyWay” was created with the aim of helping financial institutions and PSPs with adoption and management of SEPA instruments (such as SCTs and SDDs), of in

Biogen Appoints Jeff Capello as Executive Vice President and Chief Financial Officer21.11.2017 12:30Pressemelding

Biogen (Nasdaq: BIIB) announced today the appointment of Jeffrey D. Capello as Executive Vice President and Chief Financial Officer effective as of December 11, 2017. Mr. Capello will lead Biogen’s Business Planning, Tax, Treasury, Internal Audit, Accounting, and Investor Relations functions. He will report to Michel Vounatsos, CEO of Biogen, will be a member of the Executive Committee, and will be based in Cambridge, Mass. Mr. Capello brings 26 years of experience in finance. Most recently he was Executive Vice President and Chief Financial Officer of Beacon Health Options Inc. His previous experience includes founding and running his own company, Monomy Advisors, and serving as Chief Financial Officer of Ortho Clinical Diagnostics, Boston Scientific Corporation, and Perkin Elmer. Earlier in his career he was also a partner in the Boston and Amsterdam offices of PwC.

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom